Funder: National Institutes of Health

Due Dates: June 6, 2025 (New) | July 8, 2025 (Renewal/Resubmission/Revision) | September 4, 2025 (AIDS) | October 7, 2025 (New) | November 6, 2025 (Renewal/Resubmission/Revision) | January 6, 2026 (AIDS) | Additional cycles through January 8, 2028

Funding Amounts: Up to $500,000 direct costs per year; UG3 phase: 1 year; UH3 phase: up to 5 years; budgets must reflect actual project needs

Summary: Supports planning and implementation of behavioral and social intervention clinical trials related to dental, oral, or craniofacial health, using a milestone-driven UG3/UH3 cooperative agreement mechanism.

Key Information: UG3/UH3 application must be submitted as a single application; only projects meeting UG3 milestones may transition to UH3; no support for FDA-regulated drug/device/biologic trials.